Verona Pharma Plc

LONDON, January 31, 2011 - Verona Pharma plc (AIM:VRP.L) the biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, has applied to the Medicines and Healthcare Products Regulatory Agency (MHRA), the Governmental agency in the UK with responsibility for standards of safety, quality and performance of new drug treatments, to conduct clinical trials in the UK.